Janux Therapeutics (JANX) SEC Filings: History & Chart

Janux Therapeutics, Inc.(JANX)

Biotechnology · San Diego, CA

$17.28+0.74 (+4.45%)

Delayed quote: Oct 6, 2026, 11:45 AM EDT

About Janux Therapeutics, Inc.

Janux Therapeutics, Inc. is a biopharmaceutical company dedicated to developing innovative cancer therapies. The firm leverages its proprietary Tumor Activated T Cell Engager (TRACTr) platform technology to create treatments designed to activate the body's T cells to fight tumors. Currently, Janux has several promising TRACTr product candidates in their early preclinical or discovery stages, which are engineered to target specific antigens such as prostate-specific membrane antigen, epidermal growth factor receptor, and trophoblast cell surface antigen 2. In addition to its TRACTr pipeline, the company is also developing a Tumor Activated Immunomodulator (TRACIr) — a costimulatory bispecific candidate designed to enhance T cell anti-tumor activity by engaging with programmed death-ligand 1 and CD28. Furthermore, a specific focus for their EGFR-TRACTr program is addressing epidermal growth factor receptor, a target prevalent in many cancer types and already a focus of numerous approved monoclonal antibody treatments. Janux Therapeutics, Inc. was founded in 2017 and is headquartered in La Jolla, California.

San Diego, CA

113 employees

www.januxrx.com

Healthcare / Biotechnology

Sector: Healthcare
Industry: Biotechnology
CEO: David Alan Campbell

View full financials

Form	Filing Date	Accepted	Document
SC 13G/A	Aug 14, 2026	Aug 14, 2026	View filing
SC 13G/A	Aug 13, 2026	Aug 13, 2026	View filing
10-Q	Aug 6, 2026	Aug 6, 2026	View filing
8-K	Aug 6, 2026	Aug 6, 2026	View filing
4	Jul 31, 2026	Jul 31, 2026	View filing
SC 13G/A	Jul 28, 2026	Jul 28, 2026	View filing
4	Jul 10, 2026	Jul 10, 2026	View filing
8-K	Jun 23, 2026	Jun 23, 2026	View filing
4	Jun 12, 2026	Jun 12, 2026	View filing
4	Jun 12, 2026	Jun 12, 2026	View filing
4	Jun 12, 2026	Jun 12, 2026	View filing
4	Jun 12, 2026	Jun 12, 2026	View filing
4	Jun 12, 2026	Jun 12, 2026	View filing
4	Jun 12, 2026	Jun 12, 2026	View filing
4	Jun 12, 2026	Jun 12, 2026	View filing
8-K	Jun 12, 2026	Jun 12, 2026	View filing
4	Jun 4, 2026	Jun 4, 2026	View filing
SC 13G/A	May 15, 2026	May 15, 2026	View filing
4	May 13, 2026	May 13, 2026	View filing
SC 13G	May 12, 2026	May 12, 2026	View filing
10-Q	May 7, 2026	May 7, 2026	View filing
8-K	May 7, 2026	May 7, 2026	View filing
SC 13G/A	May 6, 2026	May 6, 2026	View filing
SC 13G	Apr 29, 2026	Apr 29, 2026	View filing
SC 13G	Apr 29, 2026	Apr 29, 2026	View filing
8-K	Apr 28, 2026	Apr 28, 2026	View filing
ARS	Apr 28, 2026	Apr 28, 2026	View filing
DEFA14A	Apr 28, 2026	Apr 28, 2026	View filing
DEF 14A	Apr 28, 2026	Apr 28, 2026	View filing
S-8	Feb 26, 2026	Feb 26, 2026	View filing

SEC Filings

Recent Filings